Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of intranasal tobramycin 3% spray in cystic fibrosis with sinonasal bacterial infection
2007-003628-39Phase 2Terminated
- Sponsor
- Ecupharma
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tobramycin in cystic fibrosis (CF), rhinosinusitis, Pseudomonal infection and 1 more, sponsored by Ecupharma. Primary endpoint: Nasal local tolerability. Started Apr 2008; status: terminated.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)rhinosinusitisPseudomonal infectionStaphylococcus aureus infection
Beyond the preview
Go deeper on 2007-003628-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003628-39.